Adapting to funding and operational hurdles in today’s clinical trials landscape
Against the backdrop of geopolitical tensions and economic measures such as tariffs, which are influencing supply chains across numerous industries,…
All articles by Irena Maragkou
Irena Maragkou
Irena Maragkou is a Healthcare Researcher for Clinical Trials Arena and Pharmaceutical Technology based in London, UK. Irena previously worked in consulting at Deloitte’s Strategy, M&A and Analytics Department, focusing on projects in the Pharmaceutical and Healthcare Sector. She holds an MSci degree in Neuroscience from UCL.
-
-
Japan offers competitive edge with clinical trial landscape and SMO approach
“Japan has the second biggest market for branded drugs and is the third largest market for pharmaceuticals overall,” says Kento…
-
Developing resilient strategies to overcome challenges in clinical research in Europe
At the 15th Annual Outsourcing in Clinical Trials (OCT) Europe conference, which took place between 29 and 30 April in…
-
Tough funding environment is impacting trial activity in the US, expert says
An analysis of clinical trial registries, including ClinicalTrials.gov and Australian and New Zealand registries, has shown a 20% reduction in…
-
Policy changes and digital strategies guide oncology research
Against the backdrop of the recent US Food and Drug Administration’s (FDA) staff cuts and administrative realignment, understanding accelerated approval…
-
Implementing pragmatic approaches for the patients and sites in oncology trials
Is the clinical trials field doing enough to centre the needs and concerns of patients in research? That was the…
-
Patient-centric approaches thrive on wearables and remote access in trials
A transformative application of artificial intelligence (AI) in drug development lies in its potential to match the right patient population…
-
Mapping out opportunities to reduce emissions in clinical trials
Roche is committed to reach net zero greenhouse gas emissions across Scope 1, 2 and 3 by 2045, with interim…
-
Navigating the FDA’s accelerated approval pathways for oncology drugs
“It would not be surprising to not see new FDA guidance documents issued for some period of time,” said David…
-
Patient centricity and effective designs drive clinical trial success
The aim of the EU Clinical Trials Regulation (CTR) is to harmonise the clinical trial regulation process across 27 countries…